Discover Learn and Share

New option could increase minority kidney transplants

People with blood type B who received a kidney transplant of blood type A2 kidneys had similar outcomes to those with blood type B who received blood type B kidneys.

Team’s findings could spur new treatments for type 2 diabetes

An international research team including scientists from Vanderbilt University has discovered how the diabetes drug metformin blocks glucose production by the liver. The discovery, reported Aug. 27 in the journal Nature Medicine, could lead to development of new ways to treat type 2 diabetes.

photo of David Charles and Mallory Hacker

Parkinson’s study to track impact of DBS on earliest patients

A decade after taking part in the first clinical trial of deep brain stimulation (DBS) administered during very early-stage Parkinson’s disease, participants will return to Vanderbilt University Medical Center this year to be re-evaluated.

Discovery by Vanderbilt-led group could lead to improved diabetes treatment

Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).

‘Boot camp’ draws critical care nurses from across nation

Vanderbilt’s already significant population of nurse practitioners and physician assistants swelled by more than 350 people recently, as attendees from 39 states came for the sixth annual ACNP/PA Critical Care Boot Camp.

Vanderbilt University School of Medicine moves to eighth in NIH research funding

Vanderbilt University School of Medicine (VUSM) now ranks No. 8 in the nation among U.S. medical schools in total grant support provided through the National Institutes of Health (NIH). The new ranking raises VUSM’s standing two spots from the No. 10 position it held last year.